Attached files

file filename
8-K - FORM 8-K - CRANE CO /DE/d8k.htm
EX-99.1 - EARNINGS PRESS RELEASE - CRANE CO /DE/dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
     
     2010     2009     2010     2009      

Net Sales:

          

Aerospace & Electronics

   $ 139,299      $ 146,995      $ 272,944      $ 298,942     

Engineered Materials

     58,646        41,772        112,401        79,925     

Merchandising Systems

     74,527        73,331        144,698        145,026     

Fluid Handling

     254,587        263,083        502,376        529,573     

Controls

     25,755        20,310        50,686        47,163     
                                  

Total Net Sales

   $ 552,814      $ 545,491      $ 1,083,105      $ 1,100,629     
                                  

Operating Profit:

          

Aerospace & Electronics

   $ 26,215      $ 19,099      $ 50,704      $ 36,331     

Engineered Materials

     10,172        4,580        18,712        6,067     

Merchandising Systems

     8,110        6,675        13,079        9,655     

Fluid Handling

     32,152        27,059        60,141        63,826     

Controls

     825        (1,731     951        (1,317  

Corporate

     (12,170     (10,190     (25,003     (31,186   *
                                  

Total Operating Profit

     65,304        45,492        118,584        83,376     

Interest Income

     236        465        461        1,308     

Interest Expense

     (6,657     (6,780     (13,383     (13,549  

Miscellaneous-Net

     (604     529        (625     2,240     
                                  

Income Before Income Taxes

     58,279        39,706        105,037        73,375     

Provision for Income Taxes

     18,116        11,901        31,690        22,141     
                                  

Net income before allocations to noncontrolling interests

     40,163        27,805        73,347        51,234     

Less: Noncontrolling interest in subsidiaries’ earnings

     122        38        72        157     
                                  

Net income attributable to common shareholders

     40,041        27,767        73,275        51,077     
                                  

Share Data:

          

Earnings per Diluted Share

   $ 0.67      $ 0.47      $ 1.23      $ 0.87     
                                  

Average Diluted Shares Outstanding

     59,894        58,728        59,716        58,643     

Average Basic Shares Outstanding

     58,909        58,459        58,777        58,458     

Supplemental Data:

          

Cost of Sales

   $ 361,779      $ 369,537      $ 714,050      $ 751,546     

Selling, General & Administrative

     125,731        130,462        250,471        265,707     

Depreciation and Amortization **

     15,408        14,779        29,845        29,832     

Stock-Based Compensation Expense

     3,172        2,374        6,344        4,436     

 

* Includes a charge of $7.25 million related to the settlement of a lawsuit.

 

** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     June 30,
2010
   December 31,
2009

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 335,529    $ 372,714

Accounts Receivable, net

     295,336      282,463

Current Insurance Receivable - Asbestos

     35,300      35,300

Inventories, net

     299,219      284,552

Other Current Assets

     73,026      71,317
             

Total Current Assets

     1,038,410      1,046,346

Property, Plant and Equipment, net

     274,232      285,224

Long-Term Insurance Receivable - Asbestos

     192,625      213,004

Other Assets

     395,084      406,346

Goodwill

     766,512      761,978
             

Total Assets

   $ 2,666,863    $ 2,712,898
             

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 1,032    $ 1,078

Accounts Payable

     152,533      142,390

Current Asbestos Liability

     100,300      100,300

Accrued Liabilities

     211,178      218,864

Income Taxes

     10,660      4,150
             

Total Current Liabilities

     475,703      466,782

Long-Term Debt

     398,646      398,557

Long-Term Deferred Tax Liability

     29,416      29,578

Long-Term Asbestos Liability

     672,848      720,713

Other Liabilities

     194,242      203,566

Total Equity

     896,008      893,702
             

Total Liabilities and Equity

   $ 2,666,863    $ 2,712,898
             


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended
June 30
    Six Months Ended
June 30
     
     2010     2009     2010     2009      

Operating Activities:

          

Net income attributable to common shareholders

   $ 40,041      $ 27,767      $ 73,275      $ 51,077     

Noncontrolling interest in subsidiaries’ earnings

     122        38        72        157     
                                  

Net income before allocations to noncontrolling interests

     40,163        27,805        73,347        51,234     

Depreciation and amortization

     15,408        14,779        29,845        29,832     

Stock-based compensation expense

     3,172        2,374        6,344        4,436     

Deferred income taxes

     6,538        (5,910     13,220        2,784     

Cash provided (used) for operating working capital

     11,041        6,997        (20,646     (20,622  

Other

     (12,876     (499     (10,721     (9,390  
                                  

Subtotal

     63,446        45,546        91,389        58,274     

Asbestos related payments, net of insurance recoveries

     (16,360     (15,191     (27,485     (12,535   *
                                  

Total provided by operating activities

     47,086        30,355        63,904        45,739     
                                  

Investing Activities:

          

Capital expenditures

     (4,271     (7,458     (8,390     (17,432  

Proceeds from disposition of capital assets

     42        622        42        2,325     

Payment for acquisition - net of cash acquired

     —          —          (51,167     —       
                                  

Total used for investing activities

     (4,229     (6,836     (59,515     (15,107  
                                  

Financing Activities:

          

Dividends paid

     (11,815     (11,696     (23,558     (23,384  

Reacquisition of shares on open market

     (9,990     —          (9,990     —       

Stock options exercised - net of shares reacquired

     7,675        884        12,389        247     

Excess tax benefit from stock-based compensation

     578        —          969        —       

Change in short-term debt

     (87     (6,089     (3,133     (15,405  
                                  

Total used for financing activities

     (13,639     (16,901     (23,323     (38,542  
                                  

Effect of exchange rate on cash and cash equivalents

     (13,273     16,041        (18,251     9,044     
                                  

Increase (decrease) in cash and cash equivalents

     15,945        22,659        (37,185     1,134     

Cash and cash equivalents at beginning of period

     319,584        210,315        372,714        231,840     
                                  

Cash and cash equivalents at end of period

   $ 335,529      $ 232,974      $ 335,529      $ 232,974     
                                  
* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.


CRANE CO.

Order Backlog

(in thousands)

 

     June 30,
2010
   March 31,
2010
   December 31,
2009
   September 30
2009
   June 30,
2009

Aerospace & Electronics

   $ 394,554    $ 388,169    $ 351,004    $ 369,898    $ 383,335

Engineered Materials

     12,496      14,810      12,070      8,454      9,135

Merchandising Systems

     20,346      21,947      23,522      23,574      19,955

Fluid Handling

     257,840      253,946      249,901      252,333      256,467

Controls

     28,711      26,910      27,958      27,292      28,026
                                  

Total Backlog

   $ 713,947    $ 705,782    $ 664,455    $ 681,551    $ 696,918
                                  


CRANE CO.

Non-GAAP Financial Measures

(in thousands)

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
        Percent Change
June 30, 2010
    Percent Change
June 30, 2010
 
    2010     2009     2010     2009         Three Months     Six Months  

INCOME ITEMS

             

Net Sales

  $ 552,814      $ 545,491      $ 1,083,105      $ 1,100,629        1.3   -1.6

Operating Profit

    65,304        45,492        118,584        83,376        43.6   42.2
Special Items impacting Operating Profit:              

Lawsuit Settlement—Pre-Tax (a)

    —          (500     —          7,250         

Restructuring Charges (Gains)- Pre-Tax (b)

    (885     2,295        (750     1,847         
                                     

Operating Profit before Special Items

  $ 64,419      $ 47,287      $ 117,834      $ 92,473        36.2   27.4
                                     

Percentage of Sales

    11.7     8.7     10.9     8.4      

Net Income Attributable to Common Shareholders

  $ 40,041      $ 27,767      $ 73,275      $ 51,077         

Per Share

  $ 0.67      $ 0.47      $ 1.23      $ 0.87        41.4   40.9

Special Items impacting Net Income Attributable to Common Shareholders:

             

Lawsuit Settlement—Net of Tax (a)

    —          (325     —          4,713         

Per Share

    $ (0.01     $ 0.08         

Restructuring Charges (Gains)—Net of Tax (b)

    (561     1,692        (475     1,402         

Per Share

  $ (0.01   $ 0.03      $ (0.01   $ 0.02         
                                     

Net Income Attributable To Common Shareholders Before Special Items

  $ 39,480      $ 29,134      $ 72,800      $ 57,192        35.5   27.3
                                     

Per Share

  $ 0.66      $ 0.50      $ 1.22      $ 0.98        32.9   25.0

(a)    During the three months ended March 31, 2009, the Company recorded a charge for the settlement of a lawsuit brought against the Company by a customer alleging failure of our fiberglass-reinforced plastic material. During the three months ended June 30, 2009, the Company recorded additional insurance recoveries associated with the aforementioned settlement.

 

(b)    Amounts represent restructuring charges (gains) in connection with the Restructuring Program.

         

       

    Three Months Ended
June 30,
    Six Months Ended
June 30,
                 
    2010     2009     2010     2009                  
CASH FLOW ITEMS              

Cash Provided from Operating Activities before Asbestos—Related Payments

  $ 63,446      $ 45,546      $ 91,389      $ 58,274         

Asbestos Related Payments, Net of Insurance Recoveries

    (16,360     (15,191     (27,485     (12,535   *    
                                     

Cash Provided from Operating Activities

    47,086        30,355        63,904        45,739         

Less: Capital Expenditures

    (4,271     (7,458     (8,390     (17,432      
                                     

Free Cash Flow

  $ 42,815      $ 22,897      $ 55,514      $ 28,307         
                                     

 

* Includes a $14.5 million insurance settlement receipt from the Highlands Insurance Company.

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance. In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate positive cash flow. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.